Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
about
Discovery and validation of urinary biomarkers for prostate cancerA risk prediction model for smoking experimentation in Mexican American youth.Critical review of prostate cancer predictive toolsPredicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.Nomograms for colorectal cancer: A systematic reviewIntegrated predictive model for prostatic cancer using clinical, laboratory and ultrasound data.African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients.Nomogram for prediction of prostate cancer with serum prostate specific antigen less than 10 ng/mL.Multidimensional MR spectroscopic imaging of prostate cancer in vivo.The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models.Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.External validation of an artificial neural network and two nomograms for prostate cancer detection.Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.Cancer risk prediction models: a workshop on development, evaluation, and application.Developing a new score system for patients with PSA ranging from 4 to 20 ng/mL to improve the accuracy of PCa detection.The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.Developing a new score system for patients with PSA ranging from 4 to 20 ng/mL to improve the accuracy of PCa detection.Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsyPredicting melanoma risk: theory, practice and future challenges
P2860
Q30438582-11CE3EF1-3DE1-4382-9E3A-3E52C6C0FDA3Q30588859-E54FC08F-6364-487D-8205-2097B8670C56Q34104562-D4B5BB1C-B12A-4D5F-B71B-B0F8065CD951Q35924515-C38E1A80-C8B8-442C-A9EA-3AB1EC843E9FQ36245607-9EB36F65-80D1-486F-94B6-9674F73D987AQ36300978-2F730035-D3F0-4781-95C5-0F96DD2940E1Q37167067-90BF071A-10DB-4B41-AF2E-E7735177F168Q37370466-F1B3E221-6A9B-47F4-A47C-7DB1DF7B3ACFQ37485613-7A01FAD2-855F-4599-B4A4-6B2F6C0F6437Q37622189-B67DD2A6-AE4C-4DE0-820F-B656600E223CQ38125636-4DEB55A4-1EB4-4BC0-96D9-52C6946F6480Q38165242-F0397E94-3A52-49B9-B641-D1E5F6DB00E3Q38460250-7B980CB1-18A2-4742-A746-E778CB625D71Q39213559-417A3215-11F1-42A4-9752-067ED5E41532Q39716047-DC6A4281-34EF-4C21-BEF8-13BBEF68B1D3Q39768780-D72A83AC-D8C0-4072-AD57-03561DBD91E5Q39845544-70FEC210-6200-4B35-B9C2-B48D1D04DF10Q39932994-BE627F45-4FD7-4B53-953C-67E9BD52AD9EQ40010533-08531E50-2176-47CF-B38C-A5E2A4B54D91Q40181136-408F56D5-E613-4072-81C4-0491E52EA6F7Q40730608-B020E77D-B26E-44F5-BB6A-26320975D48BQ41832537-01259BE4-B728-4C43-B5F4-32ACCAC6B1F8Q42932905-1D16BD58-2087-46A2-94A7-DA5D60D3837EQ44065523-C6993F67-A83D-4FD6-9AEC-1B907861C00DQ45953794-A4F48C65-BB3D-4083-8D81-F322D7BEF8B2Q51058451-C955CF3C-9489-46BE-868E-FB7251B49F0EQ54273712-DC9BCC0F-50EC-4CDE-9DA4-AD0563BF5B04Q57239036-0C39E53F-53F0-4F80-9E04-1C8CC498B990Q57742458-5E58F7BE-7C71-460D-8BD0-8A536D0F78BF
P2860
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@en
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@nl
type
label
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@en
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@nl
prefLabel
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@en
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@nl
P2093
P1433
P1476
Development of a nomogram that ...... antigen between 0 and 4 ng/mL.
@en
P2093
P304
P356
10.1016/S0090-4295(99)00213-7
P407
P577
1999-10-01T00:00:00Z